Table 1– Study population
Subjects n76
Age at initiation of drug yrs49±10
Median duration of sarcoidosis before initiation of treatment yrs5.0±7.8
Females %60
Race %
 European-American55
 African-American45
Smokers/ex-smokers %53
CXR stage %
 Stage 07
 Stage 119
 Stage 235
 Stage 328
  • Data are presented as mean±sd, unless otherwise stated. CXR: chest radiography.